|
Market Closed -
Nasdaq
16:00:00 2026-10-27 EDT
|
5-day change | 1st Jan Change | ||
| 37.97 USD | +1.39% |
|
-3.19% | -10.19% |
| 10-12 | UBS Initiates Coverage on Nektar Therapeutics With Neutral Rating, $53 Price Target | MT |
| 10-12 | Leerink Partners Initiates Nektar Therapeutics at Outperform, $130 Price Target | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.39% | -3.19% | -37.14% | -46.78% | -10.19% | -39.32% | +434.26% | -84.10% | -79.34% | 1.28B | |
| -3.10% | -3.43% | -12.88% | +13.18% | +56.09% | +36.29% | +67.69% | +1.93% | - | 65.28B | |
| +0.33% | +7.26% | -7.38% | -2.69% | +9.21% | +11.51% | +77.95% | +218.47% | +5,613.87% | 54.57B | |
| +0.16% | +1.73% | +8.83% | +13.66% | +18.22% | +9.89% | +102.10% | -15.79% | +259.62% | 53.59B | |
| -0.75% | +1.38% | +0.21% | +27.36% | +20.47% | +24.89% | +50.91% | +6.79% | +276.63% | 45.03B | |
| -1.30% | -4.80% | -0.26% | +12.32% | +20.49% | +16.05% | +114.76% | -0.33% | +1,015.68% | 42.17B | |
| +1.26% | -5.26% | -7.69% | -0.98% | +133.80% | +221.12% | +900.64% | +574.95% | - | 39.42B | |
| -0.74% | -4.84% | +6.31% | +6.19% | +9.41% | +14.53% | +44.45% | +3.10% | +154.40% | 32.71B | |
| -2.70% | -7.34% | -15.74% | +14.22% | +42.05% | +23.17% | +0.36% | -62.78% | - | 24.01B | |
| +1.11% | +15.18% | +30.19% | +57.08% | +47.85% | +60.27% | +49.33% | +3.20% | +162.43% | 26.5B | |
| +0.23% | -4.51% | -12.13% | -4.42% | -8.55% | -17.91% | -4.54% | -68.77% | - | 21.82B | |
| +1.75% | -0.74% | -19.30% | -9.33% | -45.44% | -42.10% | +297.65% | +259.70% | +590.12% | 20.38B | |
| -0.44% | +8.25% | +9.39% | +14.32% | +19.97% | +12.96% | +169.21% | +219.94% | +2,244.43% | 18.93B | |
| +0.44% | +13.75% | +21.81% | +59.98% | +79.89% | +83.76% | +107.91% | -16.56% | +369.19% | 17.06B | |
| -0.58% | +8.28% | +10.50% | +28.73% | +36.99% | +35.86% | +86.88% | -16.65% | +108.95% | 16.69B | |
| +0.37% | +1.49% | +11.96% | +17.09% | +49.10% | +63.42% | +223.51% | +206.81% | +498.44% | 16.13B | |
| +0.29% | +4.92% | +6.87% | -2.99% | - | - | - | - | - | 16.1B | |
| +2.59% | +1.28% | +3.03% | +4.85% | +180.86% | +162.43% | +375.61% | +1,411.75% | +779.81% | 14.75B | |
| -0.44% | +5.05% | +4.22% | +8.41% | +0.42% | +0.52% | -22.24% | -35.05% | +127.36% | 14.18B | |
| -5.62% | +0.27% | -2.96% | -11.83% | +15.55% | +3.56% | +512.43% | - | - | 14.63B | |
| Average | -0.29% | +3.99% | -0.11% | +9.92% | +35.59% | +35.84% | +188.89% | +144.81% | +865.83% | 27.76B | |
| Weighted average by Cap. | -0.52% | +2.92% | -0.11% | +12.41% | +36.56% | +39.18% | +164.88% | +121.61% | +1,253.47% |
- Stock Market
- Stocks
- NKTR Stock
- Sector Nektar Therapeutics
Select your edition
All financial news and data tailored to specific country editions
